Organ-specific and age-dependent expression of insulin-like growth factor-I (IGF-I) mRNA variants: IGF-IA and IB mRNAs in the mouse. 2005

Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
Department of Biology, Faculty of Science, Okayama University, Japan.

Insulin-like growth factor-I (IGF-I) gene generates several IGF-I mRNA variants by alternative splicing. Two promoters are present in mouse IGF-I gene. Each promoter encodes two IGF-I mRNA variants (IGF-IA and IGF-IB mRNAs). Variants differ by the presence (IGF-IB) or absence (IGF-IA) of a 52-bp insert in the E domain-coding region. Functional differences among IGF-I mRNAs, and regulatory mechanisms for alternative splicing of IGF-I mRNA are not yet known. We analyzed the expression of mouse IGF-IA and IGF-IB mRNAs using SYBR Green real-time RT-PCR. In the liver, IGF-I mRNA expression increased from 10 days of age to 45 days. In the uterus and ovary, IGF-I mRNA expression increased from 21 days of age, and then decreased at 45 days. In the kidney, IGF-I mRNA expression decreased from 10 days of age. IGF-IA mRNA levels were higher than IGF-IB mRNA levels in all organs examined. Estradiol-17beta (E2) treatment in ovariectomized mice increased uterine IGF-IA and IGF-IB mRNA levels from 3 hr after injection, and highest levels for both mRNAs were detected at 6 hr, and relative increase was greater for IGF-IB mRNA than for IGF-IA mRNA. These results suggest that expression of IGF-I mRNA variants is regulated in organ-specific and age-dependent manners, and estrogen is involved in the change of IGF-I mRNA variant expression.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
July 1996, Bone,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
April 1995, Bioscience, biotechnology, and biochemistry,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
March 1991, FEBS letters,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
August 1989, Biochemical and biophysical research communications,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
March 1990, Development (Cambridge, England),
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
January 1995, Growth, development, and aging : GDA,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
January 2006, Placenta,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
June 1996, Investigative ophthalmology & visual science,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
May 1995, European journal of endocrinology,
Takashi Ohtsuki, and Mariko Otsuki, and Yousuke Murakami, and Tetsuya Maekawa, and Takashi Yamamoto, and Koji Akasaka, and Sakae Takeuchi, and Sumio Takahashi
August 1997, Endocrinology,
Copied contents to your clipboard!